|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/14 | |
| A61K 9/00 | |||
| A61P 11/00 | |||
| A61K 45/06 | |||
| A61M 15/00 | |||
| A61K 9/16 | |||
| A61K 9/50 | |||
| A61K 31/40 | |||
| A61K 31/56 | |||
| A61K 31/58 | |||
| A61K 31/4704 |
| (11) | Number of the document | 2670395 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12705203.3 |
| Date of filing the European patent application | 2012-02-03 | |
| (97) | Date of publication of the European application | 2013-12-11 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/023727 |
| Date | 2012-02-03 |
| (87) | Number | WO 2012/106575 |
| Date | 2012-08-09 |
| (30) | Number | Date | Country code |
| 201161439527 P | 2011-02-04 | US |
| (72) |
WEERS, Jeffry, US
RAO, Nagaraja, US
TARARA, Thomas E., US
HUANG, Daniel, US
MILLER, Danforth, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DRY POWDER FORMULATIONS OF PARTICLES THAT CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATING OBSTRUCTIVE OR INFLAMMATORY AIRWAYS DISEASES |
| DRY POWDER FORMULATIONS OF PARTICLES THAT CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATING OBSTRUCTIVE OR INFLAMMATORY AIRWAYS DISEASES |